Eppendorf announces new addition to BioBLU Single-use Vessel Adaptor Kit portfolio

Editorial Checklist Reviewed
EppendorfJun 3 2014

Eppendorf is proud to announce a new addition to the BioBLU Single-use Vessel Adaptor Kit portfolio. The BioBLU 5c and 14c Adaptor Kits allow BioBLU 5c and 14c Single-use vessels to be used on and controlled by Sartorius® BioStat® B-DCU-II controllers (Heat Blanket configuration only).

The BioBLU adaptor kit portfolio continues to provide an unparalleled level of flexibility for users looking to maximize existing processes while employing all the benefits of single-use technology. BioBLU 5c and 14c Single-use vessel adaptor kits are available for Applikon®, Sartorius, and the Eppendorf line of New Brunswick™ autoclavable cell culture systems.

Source:

Eppendorf

Posted in: Device / Technology News

Comments (0)

Suggested Reading

Machine learning provide new insights into how the brain responds to heroin use
Nectin4-targeted VHH-CAR-T cells show potency against bladder cancer
New insights into bacterial division through engineered protein control
New hybrid technology enhances precision in stem cell therapy for brain diseases
Study reveals colonic inflammation as the trigger for beta cell growth in obesity
New stem cell model mimics alpha cell behavior in diabetic conditions
Influenza virus hijacks human gene regulator to evade immune system
Lysosomal lipid peroxidation drives ferroptosis in cancer cells

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
(Logout)
Post

Newsletters you may be interested in

See all Newsletters »

Terms

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

Provide Feedback

You might also like...
Next-generation "armored" CAR T cell therapy shows promising results in lymphoma patients